Your browser doesn't support javascript.
loading
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.
Batson, Jennifer; Toop, Hamish D; Redondo, Clara; Babaei-Jadidi, Roya; Chaikuad, Apirat; Wearmouth, Stephen F; Gibbons, Brian; Allen, Claire; Tallant, Cynthia; Zhang, Jingxue; Du, Chunyun; Hancox, Jules C; Hawtrey, Tom; Da Rocha, Joana; Griffith, Renate; Knapp, Stefan; Bates, David O; Morris, Jonathan C.
Afiliação
  • Batson J; Exonate Ltd , Unit 23, Cambridge Science Park, Cambridge, United Kingdom.
  • Toop HD; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham , Queen's Medical Centre, Nottingham NG2 7UH, United Kingdom.
  • Redondo C; Exonate Ltd , Unit 23, Cambridge Science Park, Cambridge, United Kingdom.
  • Babaei-Jadidi R; School of Chemistry, UNSW Australia , Sydney, Australia.
  • Chaikuad A; Structural Genomic Consortium, University of Oxford , Old Road Campus, Oxford OX3 7DQ, United Kingdom.
  • Wearmouth SF; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham , Queen's Medical Centre, Nottingham NG2 7UH, United Kingdom.
  • Gibbons B; Structural Genomic Consortium, University of Oxford , Old Road Campus, Oxford OX3 7DQ, United Kingdom.
  • Allen C; Institute for Pharmaceutical Chemistry and Buchmann Institute for Life Sciences, Johann Wolfgang Goethe-University , D-60438, Frankfurt am Main, Germany.
  • Tallant C; School of Chemistry, UNSW Australia , Sydney, Australia.
  • Zhang J; Exonate Ltd , Unit 23, Cambridge Science Park, Cambridge, United Kingdom.
  • Du C; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham , Queen's Medical Centre, Nottingham NG2 7UH, United Kingdom.
  • Hancox JC; Structural Genomic Consortium, University of Oxford , Old Road Campus, Oxford OX3 7DQ, United Kingdom.
  • Hawtrey T; School of Chemistry, UNSW Australia , Sydney, Australia.
  • Da Rocha J; School of Physiology and Pharmacology and Neuroscience, University of Bristol , BS8 1TD, Bristol, United Kingdom.
  • Griffith R; School of Physiology and Pharmacology and Neuroscience, University of Bristol , BS8 1TD, Bristol, United Kingdom.
  • Knapp S; School of Chemistry, UNSW Australia , Sydney, Australia.
  • Bates DO; School of Chemistry, UNSW Australia , Sydney, Australia.
  • Morris JC; School of Medical Sciences, UNSW Australia , Sydney, Australia.
ACS Chem Biol ; 12(3): 825-832, 2017 03 17.
Article em En | MEDLINE | ID: mdl-28135068
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Neovascularização de Coroide / Inibidores Enzimáticos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Chem Biol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Neovascularização de Coroide / Inibidores Enzimáticos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Chem Biol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido